• No results found

Corrigendum: Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases

N/A
N/A
Info
Downloaden
Protected

Academic year: 2021

Share "Corrigendum: Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Download het nu ( 1 pagina )

Hele tekst

(1)

CORRECTION published: 04 June 2019 doi: 10.3389/fgene.2019.00517

Frontiers in Genetics | www.frontiersin.org 1 June 2019 | Volume 10 | Article 517

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland *Correspondence: Frederic Y. Bois frederic.bois@certara.com Elias Zgheib elias.zgheib.pro@gmail.com Specialty section: This article was submitted to Toxicogenomics, a section of the journal Frontiers in Genetics Received: 11 May 2019 Accepted: 13 May 2019 Published: 04 June 2019 Citation: Zgheib E, Limonciel A, Jiang X, Wilmes A, Wink S, van de Water B, Kopp-Schneider A, Bois FY and Jennings P (2019) Corrigendum: Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases. Front. Genet. 10:517. doi: 10.3389/fgene.2019.00517

Corrigendum: Investigation of Nrf2,

AhR and ATF4 Activation in

Toxicogenomic Databases

Elias Zgheib1*, Alice Limonciel2, Xiaoqi Jiang3, Anja Wilmes2, Steven Wink4,

Bob van de Water4, Annette Kopp-Schneider3, Frederic Y. Bois5* and Paul Jennings2

1Laboratoire de Biomécanique et Bio-ingénierie, Sorbonne Universités – Université de Technologie de Compiègne,

Compiègne, France,2Division of Molecular and Computational Toxicology, Amsterdam Institute for Molecules, Medicines and

Systems, Vrije Universiteit Amsterdam, Amsterdam, Netherlands,3Division of Biostatistics, German Cancer Research Center,

Heidelberg, Germany,4Division of Drug Discovery and Safety, Leiden Cell Observatory High Content Imaging Screening

Facility, Leiden Academic Center for Drug Research, Leiden University, Leiden, Netherlands,5Models for Ecotoxicology and

Toxicology Unit (DRC/VIVA/METO), Institut National de l’Environnement Industriel et des Risques, Verneuil-en-Halatte, France

Keywords: transcriptomics, Nrf2, AhR, ATF4, toxicity pathways, toxicogenomic, oxidative stress

A Corrigendum on

Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases

by Zgheib, E., Limonciel, A., Jiang, X., Wilmes, A., Wink, S., van de Water, B., et al. (2018). Front. Genet. 9:429. doi: 10.3389/fgene.2018.00429

In the original article, we neglected to mention that this work was partly supported by the EU-ToxRisk project (An Integrated European “Flagship” Program Driving Mechanism-Based Toxicity Testing and Risk Assessment for the 21st Century) funded by the European Commission under the Horizon 2020 programme (Grant Agreement No. 681002).

A correction has therefore been made to the Acknowledgments:

“The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (IMIJU) under grant agreement number 115439, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. This work was supported by the 2015 CEFIC-LRI award (AL) and partly supported by the EU-ToxRisk project (An Integrated European “Flagship” Program Driving Mechanism-Based Toxicity Testing and Risk Assessment for the 21st Century) funded by the European Commission under the Horizon 2020 programme (Grant Agreement No. 681002). This publication reflects only the author’s views and neither the IMI JU nor EFPIA nor the European Commission are liable for any use that may be made of the information contained therein.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Referenties

Download het nu ( PDF - 1 pagina - 132.77 KB )

GERELATEERDE DOCUMENTEN

This is due partly to the fact that not all victims want victim support

Risks in Victims who are in the target group that is supposed to be actively referred referral are not guaranteed to be referred, as there are situations in referral practice

Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk.

proudly sees itself as “flagship” exploring new alterna- tive-to-animal approaches to chemical safety evaluation. It promotes mechanism-based toxicity testing and risk

Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity

These responses were translated into quantitative high-content live-cell imaging of induction of a selective Nrf2 target, GFP-tagged Srxn1, and the altered nuclear

Original article

Our aim was to compare early changes in double endometrial thickness (DET) and uterine volume (UV) occurring in postmenopausal breast cancer patients receiving either tamoxifen

First, the history of the EU and the European trade relations are examined, followed by the role of Turkey in this context

The 2004 enlargement and the potential accession of Turkey are considered in the light of a possible shift in trade intensity from the historical core of the EU (EU-15) to the

Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience

The approach chosen in this case study demonstrated that an AOP-based testing strategy combining different test methods that cover the various KEs can be applied in sup-

based on the original ledmac by

Numbered text is printed with marginal line numbers and can include footnotes and endnotes that are referenced to those line numbers: this is how you’ll want to print the text

Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases

ATF4 signatures size is similar to Nrf2’s signatures with a comparable proportion of activated genes: 23 genes in the all liver data signature, 28 for “Rat liver in vitro” and 14